161 related articles for article (PubMed ID: 25956659)
1. Systemic granulocyte colony-stimulating factor (G-CSF) enhances wound healing in dystrophic epidermolysis bullosa (DEB): Results of a pilot trial.
Fine JD; Manes B; Frangoul H
J Am Acad Dermatol; 2015 Jul; 73(1):56-61. PubMed ID: 25956659
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of trimethoprim in wound healing of patients with epidermolysis bullosa: a feasibility trial.
Lara-Corrales I; Parkin PC; Stephens D; Hamilton J; Koren G; Weinstein M; Sibbald RG; Pope E
J Am Acad Dermatol; 2012 Feb; 66(2):264-70. PubMed ID: 22153787
[TBL] [Abstract][Full Text] [Related]
3. A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa.
Venugopal SS; Yan W; Frew JW; Cohn HI; Rhodes LM; Tran K; Melbourne W; Nelson JA; Sturm M; Fogarty J; Marinkovich MP; Igawa S; Ishida-Yamamoto A; Murrell DF
J Am Acad Dermatol; 2013 Dec; 69(6):898-908.e7. PubMed ID: 24075228
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow cell mobilization by the systemic use of granulocyte colony-stimulating factor (GCSF) improves wound bed preparation.
Iwamoto S; Lin X; Ramirez R; Carson P; Fiore D; Goodrich J; Yufit T; Falanga V
Int J Low Extrem Wounds; 2013 Dec; 12(4):256-64. PubMed ID: 24275756
[TBL] [Abstract][Full Text] [Related]
5. Chemotaxis-driven disease-site targeting of therapeutic adult stem cells in dystrophic epidermolysis bullosa.
Alexeev V; Donahue A; Uitto J; Igoucheva O
Stem Cell Res Ther; 2016 Aug; 7(1):124. PubMed ID: 27568180
[TBL] [Abstract][Full Text] [Related]
6. Purified type I collagen wound matrix improves chronic wound healing in patients with recessive dystrophic epidermolysis bullosa.
Gorell ES; Leung TH; Khuu P; Lane AT
Pediatr Dermatol; 2015; 32(2):220-5. PubMed ID: 25557742
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor: differential action on incisional wound healing.
Jyung RW; Wu L; Pierce GF; Mustoe TA
Surgery; 1994 Mar; 115(3):325-34. PubMed ID: 7510423
[TBL] [Abstract][Full Text] [Related]
8. Using honey to heal a chronic wound in a patient with epidermolysis bullosa.
Hon J
Br J Nurs; 2005 Oct 27-Nov 9; 14(19):S4-5, S8, S10 passim. PubMed ID: 16315361
[TBL] [Abstract][Full Text] [Related]
9. Impact of low-dose calcipotriol ointment on wound healing, pruritus and pain in patients with dystrophic epidermolysis bullosa: A randomized, double-blind, placebo-controlled trial.
Guttmann-Gruber C; Piñón Hofbauer J; Tockner B; Reichl V; Klausegger A; Hofbauer P; Wolkersdorfer M; Tham KC; Lim SS; Common JE; Diem A; Ude-Schoder K; Hitzl W; Lagler F; Reichelt J; Bauer JW; Lang R; Laimer M
Orphanet J Rare Dis; 2021 Nov; 16(1):473. PubMed ID: 34749770
[TBL] [Abstract][Full Text] [Related]
10. A case of dystrophic epidermolysis bullosa improved with etanercept for concomitant psoriatic arthritis.
Gubinelli E; Angelo C; Pacifico V
Am J Clin Dermatol; 2010; 11 Suppl 1():53-4. PubMed ID: 20586512
[TBL] [Abstract][Full Text] [Related]
11. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte-Colony Stimulating Factor (G-CSF) accelerates healing of radiation induced moist desquamation of the skin.
Viswanath L; Bindhu J; Krishnamurthy B; Suresh KP
Klin Onkol; 2012; 25(3):199-205. PubMed ID: 22724569
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of oral JAK1 or JAK1/2 inhibitor for treating refractory pruritus in dystrophic epidermolysis bullosa: A retrospective case series.
Kwon IJ; Kim SE; Kim SC; Lee SE
J Dermatol; 2024 Mar; 51(3):441-447. PubMed ID: 38115742
[TBL] [Abstract][Full Text] [Related]
14. A short course of granulocyte-colony-stimulating factor to accelerate wound repair in patients undergoing surgery for sacrococcygeal pilonidal cyst: proof of concept.
Baldelli CM; Ruella M; Scuderi S; Monni M; Passera R; Omedè P; Tarella C
Cytotherapy; 2012 Oct; 14(9):1101-9. PubMed ID: 22783986
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast cell therapy enhances initial healing in recessive dystrophic epidermolysis bullosa wounds: results of a randomized, vehicle-controlled trial.
Petrof G; Martinez-Queipo M; Mellerio JE; Kemp P; McGrath JA
Br J Dermatol; 2013 Nov; 169(5):1025-33. PubMed ID: 24032424
[TBL] [Abstract][Full Text] [Related]
16. Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa.
Guide SV; Gonzalez ME; Bağcı IS; Agostini B; Chen H; Feeney G; Steimer M; Kapadia B; Sridhar K; Quesada Sanchez L; Gonzalez F; Van Ligten M; Parry TJ; Chitra S; Kammerman LA; Krishnan S; Marinkovich MP
N Engl J Med; 2022 Dec; 387(24):2211-2219. PubMed ID: 36516090
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast-based cell therapy strategy for recessive dystrophic epidermolysis bullosa.
Yan WF; Murrell DF
Dermatol Clin; 2010 Apr; 28(2):367-70, xii. PubMed ID: 20447505
[TBL] [Abstract][Full Text] [Related]
18. Clinical features of gingival lesions in patients with dystrophic epidermolysis bullosa: a cross-sectional study.
Fortuna G; Aria M; Cepeda-Valdes R; Pollio A; Moreno-Trevino MG; Salas-Alanís JC
Aust Dent J; 2015 Mar; 60(1):18-23. PubMed ID: 25721275
[TBL] [Abstract][Full Text] [Related]
19. A prospective short-term study to evaluate methodologies for the assessment of disease extent, impact, and wound evolution in patients with dystrophic epidermolysis bullosa.
Paller AS; Pope E; Rudin D; Malyala A; Ramsdell D; Johnson R; Landy H; Murrell DF;
Orphanet J Rare Dis; 2022 Aug; 17(1):314. PubMed ID: 35964087
[TBL] [Abstract][Full Text] [Related]
20. Effect of subcutaneous injection of granulocyte-macrophage colony stimulating factor (GM-CSF) on healing of chronic refractory wounds.
Malik IA; Zahid M; Haq S; Syed S; Moid I; Waheed I
Eur J Surg; 1998 Oct; 164(10):737-44. PubMed ID: 9840302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
